|

FWD1802 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1/2: 2

Top Sponsors

  • Forward Pharmaceuticals Co., Ltd.2

Indications

  • Metastatic Breast Cancer2
  • Breast Cancer2
  • Cancer2
  • ER+/HER2- Breast Cancer1
  • Locally Advanced Breast Cancer (LABC)1

Other2 trials

A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.
Phase 1/2
A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.